alexa What Determines the Response to Immunomodulatory Therapy in Multiple Myeloma?

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

What Determines the Response to Immunomodulatory Therapy in Multiple Myeloma?

Several mechanisms have been proposed to explain the activity of Immunomodulatory Drugs (IMiDs) in Multiple Myeloma (MM). These included demonstrable anti-angiogenic, antiproliferative and immune modulation effects. The precise cellular targets and molecular mechanisms have only recently become clear

 

Bedewy AML, El-Maghraby SM (2014) What Determines the Response to Immunomodulatory Therapy in Multiple Myeloma?. J Leuk (Los Angel) 2:143. doi: 10.4172/2329-6917.1000143

  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger